Novartis (NVS) Bɛn Dɛŋɛn Akɔc
Novartis
Bɛ̈ny cɔk aya$145.41Aciic 25 Sep 2026 19:59 UTC
Change+1.28%
AI forecast: NVS
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
Novartis AG manufactures prescription and over-the-counter medicines for the treatment of cardiovascular, respiratory, and infectious diseases, gastrointestinal and urinary tract disorders, as well as for oncology, neurology, transplantation, and dermatology. The company also produces vaccines and diagnostic agents, ophthalmic products, and veterinary medicines.
